Cognitive Training for Mild Cognitive Impairment
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method to assist individuals with Mild Cognitive Impairment (MCI), characterized by more memory and thinking problems than usual for their age, but not severe enough to be classified as dementia. The study tests cognitive training, a therapy focusing on everyday memory challenges and problem-solving skills. Participants will join one of two groups: one receiving cognitive training and one not. This trial may suit individuals diagnosed with MCI who do not have dementia or a history of severe mental health issues. As an unphased trial, it offers a unique opportunity to contribute to pioneering research that could enhance the understanding and treatment of MCI.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this cognitive training is safe for individuals with Mild Cognitive Impairment?
Research has shown that cognitive training is generally safe for people with Mild Cognitive Impairment (MCI). One review of 22 studies found that engaging in mental activities can reduce the risk of developing dementia by 46% over several years. This suggests that cognitive training is not only safe but may also be beneficial in the long term.
Another study found that people with MCI who participated in cognitive training improved their thinking skills and felt more confident about their cognitive abilities. No major negative side effects were reported, making it a well-tolerated option for most individuals.
Overall, evidence supports the safety of cognitive training for MCI. It appears to be a promising approach with potential benefits for thinking skills and no major negative effects reported.12345Why are researchers excited about this trial?
Researchers are excited about cognitive training for mild cognitive impairment because it offers a non-pharmaceutical approach to enhance brain function. Unlike current treatments that often rely on medications like cholinesterase inhibitors, cognitive training focuses on improving mental processes through structured exercises and activities. This method aims to strengthen neural connections and boost cognitive skills such as memory and attention, potentially delaying the progression of cognitive decline. By engaging patients in targeted cognitive tasks, this approach not only seeks to improve day-to-day functioning but also offers a personalized and interactive treatment experience.
What evidence suggests that cognitive training is effective for mild cognitive impairment?
Research shows that brain exercises can help people with Mild Cognitive Impairment (MCI). In this trial, participants will either receive cognitive training or not. Studies have found that these exercises can greatly improve memory and thinking skills. One study discovered that brain exercises slowed memory loss over five years in people with MCI. Another study showed improvements in both short-term and long-term memory. These findings suggest that brain exercises can help maintain sharp mental abilities in people with MCI.35678
Who Is on the Research Team?
Karen A Chipman, PhD
Principal Investigator
Nova Scotia Health Authority
Are You a Good Fit for This Trial?
This trial is for seniors with a clinical diagnosis of Mild Cognitive Impairment. It's designed to help those who struggle with everyday memory problems and may also have mild mood-related symptoms.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Cognitive Training
Participants undergo cognitive training focusing on everyday memory problems and problem-solving approaches
Follow-up
Participants are monitored for changes in mood, caregiver burden, memory testing, and quality of life
What Are the Treatments Tested in This Trial?
Interventions
- Cognitive training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Nova Scotia Health Authority
Lead Sponsor
Karen Chipman
Lead Sponsor
Nova Scotia Health Research Foundation
Collaborator